A comparative study on the stability of silybin and that in silymarin in buffers and biological fluids

Drug Metabolism Letters

Volumn 3, Issue 2, 2009, Pages 115-119

  Tang, Ning ^a   Wu, Danni ^a   Lu, Yi ^a,b   Chen, Jian ^a   Zhang, Bei ^a   Wu, Wei ^a,b  

^a FUDAN UNIVERSITY   (China)

^b NONE   (China)

Author keywords

Biological fluid; Buffer; Silybin; Silymarin; Stability; Synergy

Indexed keywords

BUFFER; CHLORIDE; CITRIC ACID; PHOSPHATE; SILIBININ; SILYMARIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FLUID; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DEGRADATION; DRUG HALF LIFE; DRUG POTENTIATION; DRUG STABILITY; DRUG STRUCTURE; INTESTINE FLUID; LIVER HOMOGENATE; MALE; NONHUMAN; PH; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTIOXIDANTS; BUFFERS; DRUG STABILITY; HYDROGEN-ION CONCENTRATION; INTESTINAL SECRETIONS; LIVER; MALE; RATS; RATS, WISTAR; SILYMARIN;

EID: 69949084393     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/187231209788654072     Document Type: Article

References (21)

1. Flora, K.; Hahn, M.; Rosen, H.; Benner, K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am. J. Gastroenterol., 1998, 93(2), 139-143.
2. Pepping, J. Milk thistle: Silybum marianum. Am. J. Health-System Pharm., 1999, 56(12), 1195-1197.
3. Lee, D.Y.; Liu, Y. Molecular Structure and Stereochemistry of Silybin A, Silybin B, Isosilybin A, and Isosilybin B, Isolated from Silybum marianum (Milk Thistle). J. Nat. Prod., 2003, 66(9), 1171-1174.
4. Lee, J. I.; Hsu, B. H.; Wu, D.; Barrett, J. S. Separation and characterization of silybin, isosilybin, silydianin and silychristin in milk thistle extract by liquid chromatography-electrospray tandem mass spectrometry. J. Chromatogr. A, 2006, 1116(1-2), 57-68.
5. Wachter, W.; Zaeske, H. Process for the manufacture of flavanolignan preparation with improved release and absorbability, compositions obtainable thereby and their use for the preparation of pharmaceuticals. 2000, US Patent 6020384.
6. Comoglio, A.; Tomasi, A.; Malandrino, S.; Poli, G.; Albano, E. Scavenging effect of silipide, a new silybin-phospholipid complex on ethanol-derived free radicals. Biochem. Pharmacol., 1995, 50(8), 1313-1316.
7. Schandalik, R.; Gatti, G.; Perucca, E. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients. Arzneim-Forsch, 1992, 42(7), 964-968.
8. Wu, W.; Wang, Y.; Que, L. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm., 2006, 63(3), 288-294.
9. Sun, N.; Wei, X.; Wu, B.; Chen, J.; Lu, Y.; Wu, W. Enhanced dissolution of silymarin/polyvinylpyrrolidone solid dispersion pellets prepared by a one-step fluid-bed coating technique. Powd. Tech., 2007, 182(1), 72-80.
10. Williamson, E. M. Synergy and other interactions in phytomedicines. Phytomedicine, 2001, 8(5), 401-409.
11. Bilia, A. R.; Bergonzi, M. C.; Morgenni, F.; Mazzi, G.; Vincieri, F. F. Evaluation of chemical stability of St. John's wort commercial extract and some preparations. Int. J. Pharm., 2001, 213(1-2), 199-208.
12. Bilia, A. R.; Bergonzi, M. C.; Gallori, S.; Mazzi, G.; Vincieri, F. F. Stability of the constituents of Calendula, milk-thistle and passion-flower tinctures by LC-DAD and LC-MS. J. Pharm. Biomed. Anal., 2002, 30(3), 613-624.
13. Bilia, A. R.; Bergonzi, M. C.; Mazzi, G.; Vincieri, F. F. Analysis and stability of the constituents of artichoke and St. John's wort tinctures by HPLC-DAD and HPLC-MS. Drug Dev. Ind. Pharm., 2002, 28(5), 609-619.
14. Bilia, A. R.; Eterno, F.; Bergonzi, M. C.; Mazzi, G.; Vincieri, F. F. Evaluation of the content and stability of the constituents of mother tinctures and tinctures: The case of Crataegus oxyacantha. L. and Hieracium pilosella L. J. Pharm. Biomed. Anal., 2007, 44(1), 70-78.
15. Lu, C.; Lu, Y.; Chen, J.; Zhang, W.; Wu, W. Synchronized and sustained release of multiple components in silymarin from erodible glyceryl monostearate matrix system. Eur. J. Pharm. Biopharm., 2007, 66(2), 210-219.
16. Bai, T. C.; Yan, G. B.; Hu, J.; Zhang, H. L.; Huang, C. G. Solubility of silybin in aqueous poly(ethylene glycol) solution. Int. J. Pharm., 2006, 308(1-2), 100-106.
17. Zhang, T. T.; Xu, W.; Hu, S. L.; He, Z. G. Determination of equilibrium solubility of silibinin in various medium and its apparent oil/water partition coefficient. Chin. Pharm. J., 2006, 41(20), 1569-1571.
18. Han, Y. H.; Lou, H. X.; Ren, D. M.; Sun, L. R.; Ma, B.; Ji, M. Stereoselective metabolism of silybin diastereoisomers in the glucuronidation process. J. Pharm. Biomed. Anal., 2004, 34(5), 1071-1078.
19. Blumenthal, M.; Goldberg, A.; Brinkmann, J. Herbal Medicine, Integrative Medicine Communications, 2000, Newton.
20. Zhang, H. Y. Theoretical elucidation of structure-activity relationship of flavonoid antioxidants. Sci. China B, 1999, 42(1), 106-112.
21. Weyhenmeyer, R.; Mascher, H.; Birkmayer, J. Study on dose-linearity of the pharmacokinetics of silibinin diastereomers using a new stereospecific assay. Int. J. Clin. Pharmacol. Ther. Toxicol., 1992, 30(4), 134-138.